3JOHNSON DJ,LI W,ADAMS TE,et al.Antithrombin S195 A factor Xa-heparin structure reveals the allosteric mechanism of antitrombin activation[J1.EMBO J,2006,25(9):2029-2037.
4IZAGUIRRE G,SWANSON R,RAJA SM,et al.Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin[J].J Biol Chem,2007,282(46):33609-33622.
5OISON ST,RICHARD b,IZAGUIRRE G,et al.Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteisea.A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors[J].Biochimie,2010[Epub a head of print].
6IZAGUIRRE G,OLSON ST.Residues Tyr 253 and GIu255 in strand 3 of B-sheet C of antithrombin are key determinants of an exosite made accessible by heparin activation to promote rapid inhibition of factors Xa and Dla[J].J Biol Chem,2006,281(19):13424-13432.
7FITCHES AC,LEWANDOWSKI K,OLDS RJ.Creation of an additional glycwsylation site as a mechanism for type I antithrombin deficiency[J].Thromb Haemost,2001,86(4):1023-1027.
8TANAKA Y,UEDA K,OZAWA T,et al.Intracellular accumulation of antithrombin Morioka(C95 R),a novel mutation causing type I Chinese Journal of Thrombosis and Hemostasis 2011 Vol 17 No 1 antithrombin deficiency[J].J Biol Chem,2002,277(52):51058-51067.
4Lane D A, Bayston T, Olds R J, et al. Antithrombin mutation database:2nd(1997) update[J]. Thromb Haemost, 1997,77:197.
5Tokunagaa F, Shirotania H, Hara K, et al. Intracellular degradation of secretion defect-type mutants of antithrombin is inhibited by proteasomal inhibitors[J]. FEBS Letters, 1997,412:65.
6Fitton HL, Walker ID, Jones L, et al. Five antithrombin variants, four associated with thrombosis[J]. Blood Coagul Fibrinolysis, 1997,8:145.
7Nagaizumi K, Inaba H, Amano K, et al. Five novel and four recurrent point mutations in the antithrombin gene causing venous thrombosis[J].Int J Hematol, 2003,78:79.
8Tanaka Y, Ueda K, Ozawa T, et al. Intracellular Accumulation of Antithrombin Morioka (C95R), a Novel Mutation Causing Type Ⅰ Antithrombin Deficiency[J]. J Biol Chem, 2002,277:51058.
9Fitches AC, Lewandowski K, Olds RJ. Creation of an Additional Glycosylation Site as a Mechanism for Type Ⅰ Antithrombin Deficiency[J].Thromb Haemost, 2001,86:1023.
10Chuwdhury V, Olds R. J, Lane D. A, et al. Identification of nine novel mutations in type Ⅰ antithrombin deficiency by heteroduplex screening[J]. BrJ Heamatol, 1993,84:656.
